Literature DB >> 21768525

Interleukin 10 deficiency exacerbates toll-like receptor 3-induced preeclampsia-like symptoms in mice.

Piyali Chatterjee1, Valorie L Chiasson, Shelley E Kopriva, Kristina J Young, Victor Chatterjee, Kathleen A Jones, Brett M Mitchell.   

Abstract

Preeclampsia may result from overactivation of the maternal immune system and is characterized by endothelial dysfunction and excessive inflammation. Given the importance of maternal immune system regulation and anti-inflammatory cytokines in normotensive pregnancies, we hypothesized that maternal immune system activation via Toll-like receptor 3 during pregnancy would cause preeclampsia-like symptoms in mice, which would be made worse by deficiency of the anti-inflammatory cytokine interleukin 10. The Toll-like receptor 3 agonist polyinosine-polycytidylic acid (poly I:C) caused hypertension, endothelial dysfunction, and proteinuria in mice only when pregnant. In the absence of poly I:C, pregnant interleukin 10 knockout mice exhibited a significant increase in systolic blood pressure, endothelial dysfunction, and serum proinflammatory cytokines, as well as aortic and placental platelet-endothelial cell adhesion molecule expression compared with pregnant wild-type mice. Deficiency of interleukin 10 further augmented these measures in poly I:C-treated pregnant mice. In addition, sera from poly I:C-treated pregnant wild-type mice significantly decreased relaxation responses and increased platelet-endothelial cell adhesion molecule expression in isolated aortas from nonpregnant wild-type mice, and these effects were augmented by sera from poly I:C-treated interleukin 10 knockout mice. Coincubation with recombinant interleukin 10 normalized relaxation responses and platelet-endothelial cell adhesion molecule expression in all of the groups. Collectively, Toll-like receptor 3 activation during pregnancy causes preeclampsia-like symptoms, which are exacerbated by the absence of interleukin 10. Exogenous interleukin 10 treatment had beneficial effects on endothelial function and may be beneficial in women with preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768525     DOI: 10.1161/HYPERTENSIONAHA.111.172114

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Activation of Toll-like receptor 3 increases mouse aortic vascular smooth muscle cell contractility through ERK1/2 pathway.

Authors:  Trevor Hardigan; Kathryn Spitler; Takayuki Matsumoto; Maria Alicia Carrillo-Sepulveda
Journal:  Pflugers Arch       Date:  2015-03-01       Impact factor: 3.657

Review 2.  Dysregulation of T cell subsets in the pathogenesis of hypertension.

Authors:  Songcang Chen; Devendra K Agrawal
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

3.  Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Kelsey R Bounds; Piyali Chatterjee; Lochana Manandhar; Abhinandan R Pakanati; Marcos Hernandez; Bilal Aziz; Brett M Mitchell
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

4.  IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia.

Authors:  Ashlyn Harmon; Denise Cornelius; Lorena Amaral; Adrienne Paige; Florian Herse; Tarek Ibrahim; Gerd Wallukat; Jessica Faulkner; Janae Moseley; Ralf Dechend; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2015-05-21       Impact factor: 2.108

Review 5.  The immune system in hypertension.

Authors:  David G Harrison
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 6.  Interleukin-10: a pleiotropic regulator in pregnancy.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2014-10-01       Impact factor: 3.886

Review 7.  Renal effects of cytokines in hypertension.

Authors:  Yi Wen; Steven D Crowley
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

Review 8.  Current model systems for the study of preeclampsia.

Authors:  M L Martinez-Fierro; G P Hernández-Delgadillo; V Flores-Morales; E Cardenas-Vargas; M Mercado-Reyes; I P Rodriguez-Sanchez; I Delgado-Enciso; C E Galván-Tejada; J I Galván-Tejada; J M Celaya-Padilla; I Garza-Veloz
Journal:  Exp Biol Med (Maywood)       Date:  2018-02-07

Review 9.  Toll-like Receptors in the Vascular System: Sensing the Dangers Within.

Authors:  Styliani Goulopoulou; Cameron G McCarthy; R Clinton Webb
Journal:  Pharmacol Rev       Date:  2016-01       Impact factor: 25.468

Review 10.  The immune system in hypertension.

Authors:  Daniel W Trott; David G Harrison
Journal:  Adv Physiol Educ       Date:  2014-03       Impact factor: 2.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.